Laboratoires Expanscience Selects DynaSys Cloud DSCP Modules For Global Supply Chain Optimization

SANTA BARBARA, Calif.--(BUSINESS WIRE)--DynaSys, a leading provider of demand and supply chain planning (DSCP) solutions, today announced that Laboratoires Expanscience (“Expanscience”), a pharmaceutical and dermo-cosmetics laboratory, has chosen the Demand Planning, Distribution Planning and Production Planning modules of the DynaSys Cloud DSCP suite to help optimize sales forecasting, inventory and procurement management. Laboratoires Expanscience, headquartered in Courbevoie, France, will implement the cloud-based solution for its French and international facilities. DynaSys is a division of QAD Inc. (Nasdaq:QADA) (Nasdaq:QADB).

“We were attracted to the business features of the DynaSys solution because it met our supply chain optimization needs. We also knew that deploying in the cloud would facilitate global implementation”

“We need a solution that is both agile and flexible so as to ensure its sustainability within the company,” explains Johan Boutmar, CIO at Expanscience. “It has to be able to meet our current needs while also allowing us to address future demands. DynaSys fits in well with the expertise of our supply chain teams and supports our international growth. DynaSys gives our Supply Chain team an opportunity to optimize its processes while enabling the IT team to standardize its information system with a reliable and robust solution.”

Expanscience conducted extensive market research to identify a demand and supply chain planning vendor that could help them meet their goals. Laboratoires Expanscience chose the DynaSys solutions because they anticipate the following benefits:

• Streamlined processes and enhanced visibility and cooperation throughout the company’s supply chain.
• Increased reliability of forecasts between the company’s affiliates.
• Optimized Master Production Schedule and Sales and Operations Planning (S&OP).
• An intuitive user interface that enables users to quickly become proficient.

“We were attracted to the business features of the DynaSys solution because it met our supply chain optimization needs. We also knew that deploying in the cloud would facilitate global implementation,” said David Adoutte, Director of the Expanscience Supply Chain. “Our final decision, however, was based on the human factor - specifically the expertise of the DynaSys project team and their methodology, which focuses on skills transfer. We also liked the user experience of DynaSys Cloud DSCP, which we think will be a huge advantage for us as we deploy it to 14 affiliates in almost 100 countries. Finally, our choice of DynaSys fits well into our in-process core model project for IT systems, which we plan to complete by 2018.”

“We are particularly proud to participate in the evolution of IT systems at Expanscience,” said DynaSys Managing Director Ariel Weil. “Our cloud-based DSCP solution will be key to Expanscience supply chain planning. They can count on our innovative technology and our experience in the pharmaceutical and cosmetology industries to support their growth.”

About Expanscience:

Expanscience is an independent pharmaceutical and dermo-cosmetics laboratory which generated turnover of €272.3 million in 2015, with 51.3 percent coming from international sales. Expanscience employs 977 people. For more than 60 years, the company has earned an international reputation for its professionalism, innovation, and expertise in skin care and in the treatment of arthritis. Its products include two leading brands, Piascledine 300 and Mustela, which are sold in 99 countries (85 countries distributing our products and 14 affiliates). Expanscience also develops and sells active ingredients of natural origin intended for the cosmetics industry in France and internationally. The company incorporates the full value chain, from research to production to distribution. Its CSR policy, in place for 10 years, was acclaimed as being exemplary by Afaq 26000 in 2013.

Find out more: www.expanscience.com

About DynaSys – Effective Enterprise Demand and Supply Chain Planning

DynaSys, a division of QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB), provides Demand and Supply Chain Planning solutions. With 30 years of experience, DynaSys provides an integrated and collaborative planning solution that allows businesses to optimize their supply chains, including sales and operations planning, demand planning, and network, inventory and business resources optimizations. DynaSys software enables customers and partners in the consumer goods, life sciences, food and beverage, high tech, automotive, distribution and wholesale verticals to meet their goals of better managing Demand and Supply Chain Planning, and becoming more Effective Enterprises.

For more information about DynaSys, visit www.dys.com or email contact@dys.com.

About QAD – The Effective Enterprise

QAD Inc. (Nasdaq:QADA) (Nasdaq:QADB) is a leading provider of enterprise software and services designed for global manufacturing companies. For more than 35 years, QAD has provided global manufacturing companies with QAD Enterprise Applications, an enterprise resource planning (ERP) system that supports operational requirements, including financials, manufacturing, demand and supply chain planning, customer management, business intelligence and business process management. QAD Enterprise Applications is offered in flexible deployment models in the cloud, on-premise, or in a blended environment. With QAD, customers and partners in the automotive, consumer products, food and beverage, high technology, industrial products and life sciences industries can better align daily operations with their strategic goals to meet their vision of becoming more Effective Enterprises.

For more information about QAD, call +1 805-566-6000, visit www.qad.com.

“QAD” is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.

Note to Investors: This press release contains certain forward-looking statements made under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding projections of revenue, income and loss, capital expenditures, plans and objectives of management regarding the Company’s business, future economic performance or any of the assumptions underlying or relating to any of the foregoing. Forward-looking statements are based on the company’s current expectations. Words such as “expects,” “believes,” “anticipates,” “could,” “will likely result,” “estimates,” “intends,” “may,” “projects,” “should,” “would,” “might,” “plan” and variations of these words and similar expressions are intended to identify these forward-looking statements. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to: risks associated with our cloud service offerings, such as defects and disruptions in our services, our ability to properly manage our cloud service offerings, our reliance on third-party hosting and other service providers, and our exposure to liability and loss from security breaches; demand for the company’s products, including cloud service, licenses, services and maintenance; pressure to make concessions on our pricing and changes in our pricing models; protection of our intellectual property; dependence on third-party suppliers and other third-party relationships, such as sales, services and marketing channels; changes in our revenue, earnings, operating expenses and margins; the reliability of our financial forecasts and estimates of the costs and benefits of transactions; the ability to leverage changes in technology; defects in our software products and services; third-party opinions about the company; competition in our industry; the ability to recruit and retain key personnel; delays in sales; timely and effective integration of newly acquired businesses; economic conditions in our vertical markets and worldwide; exchange rate fluctuations; and the global political environment. For a more detailed description of the risk factors associated with the company and factors that may affect our forward-looking statements, please refer to the company’s latest Annual Report on Form 10-K and, in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. Management does not undertake to update these forward-looking statements except as required by law.